| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | actin filament depolymerization | 7.56e-06 | 66 | 147 | 6 | GO:0030042 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 9.14e-06 | 144 | 147 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | sulfur oxidation | 5.05e-05 | 2 | 147 | 2 | GO:0019417 | |
| Domain | ARM-type_fold | RALGAPA1 DOCK9 UBR4 CKAP5 ARMC9 BTAF1 XPO1 IPO4 LYST FOCAD URB1 MROH2B UTP20 HEATR3 | 4.49e-07 | 339 | 146 | 14 | IPR016024 |
| Domain | HEAT_REPEAT | 1.23e-06 | 70 | 146 | 7 | PS50077 | |
| Domain | HEAT | 5.96e-06 | 58 | 146 | 6 | IPR000357 | |
| Domain | FAD-bd | 9.20e-06 | 6 | 146 | 3 | IPR002938 | |
| Domain | FAD_binding_3 | 9.20e-06 | 6 | 146 | 3 | PF01494 | |
| Domain | - | 1.27e-05 | 39 | 146 | 5 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.89e-05 | 46 | 146 | 5 | IPR011042 | |
| Domain | HEAT | 3.56e-05 | 48 | 146 | 5 | PF02985 | |
| Domain | Sugar_transporter_CS | 1.09e-04 | 32 | 146 | 4 | IPR005829 | |
| Domain | ATPase_dyneun-rel_AAA | 1.60e-04 | 14 | 146 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.60e-04 | 14 | 146 | 3 | PF07728 | |
| Domain | SUGAR_TRANSPORT_2 | 2.94e-04 | 17 | 146 | 3 | PS00217 | |
| Domain | Synaptophysin/porin | 3.60e-04 | 4 | 146 | 2 | IPR001285 | |
| Domain | - | 3.63e-04 | 222 | 146 | 8 | 1.25.10.10 | |
| Domain | UDPGT | 5.61e-04 | 21 | 146 | 3 | PF00201 | |
| Domain | UDPGT | 5.61e-04 | 21 | 146 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 5.61e-04 | 21 | 146 | 3 | IPR002213 | |
| Domain | SUGAR_TRANSPORT_1 | 8.40e-04 | 24 | 146 | 3 | PS00216 | |
| Pubmed | The MICAL proteins and rab1: a possible link to the cytoskeleton? | 3.14e-07 | 4 | 150 | 3 | 15694364 | |
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 3.14e-07 | 4 | 150 | 3 | 24440334 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | UBR4 DTL ELP1 ACTG2 BTAF1 RDH13 XPO1 IPO4 GGCX NUBP2 CDKAL1 DDX3X MRPL4 TARDBP URB1 MDN1 ICMT MTR USP15 SLC27A4 | 5.23e-07 | 1257 | 150 | 20 | 37317656 |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 12110185 | ||
| Pubmed | RAPGEF6 ELP1 BTAF1 DDX3X PARP4 EIF2D BUB1 MTR AFDN MICAL3 PPIP5K2 ZBED1 HEATR3 SLC27A4 | 9.60e-07 | 650 | 150 | 14 | 38777146 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.23e-06 | 19 | 150 | 4 | 23281178 | |
| Pubmed | Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6. | 1.56e-06 | 6 | 150 | 3 | 1427910 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.93e-06 | 202 | 150 | 8 | 33005030 | |
| Pubmed | TET2 ATP6V1B2 TRIO TTLL5 UBR4 CKAP5 SH3GLB2 UBASH3A DDX3X FOCAD UBA7 PSMG2 SACS MICAL2 ZNF92 BTG3 ENPP5 AFDN ZNF292 | 3.01e-06 | 1285 | 150 | 19 | 35914814 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DYNC2H1 UBR4 DTL ELP1 BTAF1 XPO1 IPO4 CDKAL1 CCNB1 URB1 BAIAP2L1 MTR UTP20 POMK HEATR3 SLC27A4 | 3.44e-06 | 942 | 150 | 16 | 31073040 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIO DYNC2H1 UBR4 CKAP5 ELP1 XPO1 IPO4 SLC2A1 DDX3X MRPL4 TARDBP URB1 MDN1 STARD9 MTR UTP20 AFDN ATL2 DNAH5 SLC27A4 | 3.54e-06 | 1425 | 150 | 20 | 30948266 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CNNM2 UBR4 DTL CKAP5 ELP1 DUSP19 XPO1 IPO4 ECI1 CDKAL1 CCNB1 TBCCD1 PTPN6 ARL10 AFDN SLC27A4 | 5.24e-06 | 974 | 150 | 16 | 28675297 |
| Pubmed | UBR4 CKAP5 ELP1 BTAF1 XPO1 SLC2A1 GGCX DDX3X TARDBP POMK USP15 HEATR3 SLC27A4 | 5.97e-06 | 657 | 150 | 13 | 36180527 | |
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 22511988 | ||
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 1339448 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | VIL1 ATP6V1B2 DYNC2H1 SLC26A4 ARMC9 ITIH4 DDX3X COL18A1 PARP4 PTPN6 EML5 EGF BAIAP2L1 SLC22A2 SCN10A SYPL1 | 8.86e-06 | 1016 | 150 | 16 | 19056867 |
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 23642732 | ||
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 11465080 | ||
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 9.23e-06 | 10 | 150 | 3 | 22558097 | |
| Pubmed | ECI1 GGCX NUBP2 CDKAL1 DDX3X COL18A1 ARL10 MDN1 SYPL1 MICAL3 ATL2 POMK HEATR3 | 9.45e-06 | 686 | 150 | 13 | 28380382 | |
| Pubmed | EPS15 ATP6V1B2 UBR4 CKAP5 XPO1 IPO4 SLC2A1 DDX3X TARDBP PSMG2 MDN1 AFDN USP15 | 1.30e-05 | 707 | 150 | 13 | 19738201 | |
| Pubmed | RALGAPA1 MICAL1 ATP6V1B2 CARMIL2 MAP1A TRIO TNC SLC2A14 CKAP5 ELP1 DAPK1 XPO1 ECI1 SLC2A1 TENM4 SACS MICAL2 AFDN MICAL3 | 1.38e-05 | 1431 | 150 | 19 | 37142655 | |
| Pubmed | 1.68e-05 | 12 | 150 | 3 | 24169621 | ||
| Pubmed | 1.68e-05 | 12 | 150 | 3 | 19419973 | ||
| Pubmed | 1.68e-05 | 12 | 150 | 3 | 16595651 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.68e-05 | 12 | 150 | 3 | 11434514 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15456853 | ||
| Pubmed | Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma. | 1.85e-05 | 2 | 150 | 2 | 26183839 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 8068691 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24641623 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 8093859 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 34910522 | ||
| Pubmed | The role of TET2-mediated ROBO4 hypomethylation in the development of diabetic retinopathy. | 1.85e-05 | 2 | 150 | 2 | 37430272 | |
| Pubmed | A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis. | 1.85e-05 | 2 | 150 | 2 | 29343848 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19887451 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 27012366 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11687802 | ||
| Pubmed | Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. | 1.85e-05 | 2 | 150 | 2 | 32518264 | |
| Pubmed | Molecular basis of oligoubiquitin-dependent internalization of membrane proteins in Mammalian cells. | 1.85e-05 | 2 | 150 | 2 | 16497223 | |
| Pubmed | Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. | 1.85e-05 | 2 | 150 | 2 | 22918213 | |
| Pubmed | Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3. | 1.85e-05 | 2 | 150 | 2 | 30131165 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25695618 | ||
| Pubmed | Differential regulation of actin microfilaments by human MICAL proteins. | 1.85e-05 | 2 | 150 | 2 | 22331357 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 14570768 | ||
| Pubmed | 2.05e-05 | 128 | 150 | 6 | 30995482 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.18e-05 | 13 | 150 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.18e-05 | 13 | 150 | 3 | 25246029 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 TET2 RAPGEF6 CARMIL2 TRIO DTL CKAP5 LYST DDX3X MDN1 BAIAP2L1 STARD9 AFDN PPIP5K2 | 2.34e-05 | 861 | 150 | 14 | 36931259 |
| Pubmed | RALGAPA1 EPS15 ATP6V1B2 DYNC2H1 TTLL5 UBR4 ELP1 IPO4 ATF6B SLC2A1 CDKAL1 MRPL4 COL18A1 URB1 MDN1 SACS SLC20A1 MTR EIF2AK3 | 2.34e-05 | 1487 | 150 | 19 | 33957083 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 ATG10 TRIO DOCK9 UBR4 BTAF1 LYST SLC2A1 FOCAD CPTP URB1 SLC8B1 MDN1 PIGW MICAL3 ATP2A3 | 2.47e-05 | 1105 | 150 | 16 | 35748872 |
| Pubmed | 2.76e-05 | 14 | 150 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2.76e-05 | 14 | 150 | 3 | 10836148 | |
| Pubmed | 2.76e-05 | 14 | 150 | 3 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 2.76e-05 | 14 | 150 | 3 | 14672974 | |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 3.83e-05 | 374 | 150 | 9 | 19625176 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 4.23e-05 | 16 | 150 | 3 | 19414484 | |
| Pubmed | 4.42e-05 | 381 | 150 | 9 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 4.51e-05 | 382 | 150 | 9 | 19170196 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 5.12e-05 | 17 | 150 | 3 | 20639394 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MAP1A DYNC2H1 DTL ELP1 SH3GLB2 IPO4 BAIAP2L1 ZNF92 BUB1 MTR HSF2 | 5.27e-05 | 588 | 150 | 11 | 38580884 |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 31575075 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 20106972 | ||
| Pubmed | BUB1B promotes multiple myeloma cell proliferation through CDC20/CCNB axis. | 5.53e-05 | 3 | 150 | 2 | 25698537 | |
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 5.53e-05 | 3 | 150 | 2 | 30801007 | |
| Pubmed | Differential substrate use in EGF- and oncogenic KRAS-stimulated human mammary epithelial cells. | 5.53e-05 | 3 | 150 | 2 | 33811729 | |
| Pubmed | Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. | 5.53e-05 | 3 | 150 | 2 | 9108057 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 24243341 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 12051676 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 32886326 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 1730609 | ||
| Pubmed | Monitoring phosphatase reactions of multiple phosphorylated substrates by reversed-phase HPLC. | 5.53e-05 | 3 | 150 | 2 | 17416557 | |
| Pubmed | Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. | 5.53e-05 | 3 | 150 | 2 | 17213475 | |
| Pubmed | Gestational changes of glucose transporter gene expression in the mouse placenta and decidua. | 5.53e-05 | 3 | 150 | 2 | 8905482 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 31561359 | ||
| Pubmed | Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. | 5.53e-05 | 3 | 150 | 2 | 8524869 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19550108 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 25723178 | ||
| Pubmed | Placental glucose transporter expression is regulated by glucocorticoids. | 5.53e-05 | 3 | 150 | 2 | 10199793 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 7926364 | ||
| Pubmed | Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes. | 5.53e-05 | 3 | 150 | 2 | 30765335 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 3170580 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 21383159 | ||
| Pubmed | Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. | 5.53e-05 | 3 | 150 | 2 | 15507209 | |
| Pubmed | The prognostic value of autophagy related genes with potential protective function in Ewing sarcoma. | 5.53e-05 | 3 | 150 | 2 | 35902797 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19553323 | ||
| Pubmed | Interactions of the scid or beige mutations with the viable motheaten mutation. | 5.53e-05 | 3 | 150 | 2 | 8781712 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 24558379 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19327547 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 34205668 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 28746873 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 23611809 | ||
| Pubmed | 6.12e-05 | 18 | 150 | 3 | 1765007 | ||
| Pubmed | 7.33e-05 | 407 | 150 | 9 | 12693553 | ||
| Pubmed | TICRR RAPGEF6 DOCK9 DTL FRMPD1 UNC13D SLC2A1 TBCCD1 TARDBP COL18A1 URB1 SLC7A3 EML5 SLC20A1 PIGW | 7.46e-05 | 1084 | 150 | 15 | 11544199 | |
| Pubmed | 7.66e-05 | 52 | 150 | 4 | 26590417 | ||
| Pubmed | 7.66e-05 | 52 | 150 | 4 | 22219177 | ||
| Pubmed | RALGAPA1 EPS15 TRIO DTL GGCX CDKAL1 SLC20A1 MTR PPIP5K2 ATL2 USP15 SLC27A4 | 8.58e-05 | 733 | 150 | 12 | 34672954 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPS15 SWAP70 UBR4 CKAP5 SH3GLB2 XPO1 IPO4 ECI1 SLC2A1 DDX3X MRPL4 TARDBP BAIAP2L1 SLC20A1 AFDN ATL2 SLC27A4 | 9.03e-05 | 1367 | 150 | 17 | 32687490 |
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 9.47e-05 | 421 | 150 | 9 | 19692168 | |
| Interaction | AQP3 interactions | 1.05e-05 | 239 | 147 | 10 | int:AQP3 | |
| Interaction | HCST interactions | 2.01e-05 | 205 | 147 | 9 | int:HCST | |
| Interaction | C3orf18 interactions | 2.16e-05 | 115 | 147 | 7 | int:C3orf18 | |
| Interaction | CA9 interactions | XPO1 IPO4 CDKAL1 MICAL2 SLC20A1 EIF2AK3 HEATR3 SLC27A4 AMIGO2 | 2.92e-05 | 215 | 147 | 9 | int:CA9 |
| Interaction | GPR182 interactions | BTAF1 ACAD10 XPO1 GGCX FOCAD URB1 MDN1 ICMT UTP20 ATL2 ATP2A3 GPAT2 SLC27A4 | 2.99e-05 | 455 | 147 | 13 | int:GPR182 |
| Cytoband | 2q37 | 3.22e-06 | 31 | 150 | 4 | 2q37 | |
| Cytoband | 15q15.3 | 7.46e-05 | 25 | 150 | 3 | 15q15.3 | |
| GeneFamily | Solute carriers | SLC25A27 SLC26A4 SLC35C2 SLC2A14 SLC19A3 SLC2A1 SLC7A3 SLC8B1 SLC20A1 SLC22A2 SLC27A4 | 1.41e-05 | 395 | 102 | 11 | 752 |
| GeneFamily | UDP glucuronosyltransferases | 7.68e-04 | 32 | 102 | 3 | 363 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-07 | 174 | 150 | 8 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-07 | 200 | 150 | 8 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.12e-06 | 174 | 150 | 7 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 184 | 150 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 184 | 150 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-06 | 184 | 150 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-06 | 188 | 150 | 7 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.86e-06 | 145 | 150 | 6 | 37580218f6a6f65a1d827cbcf59465f8827f9a55 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-05 | 165 | 150 | 6 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-05 | 165 | 150 | 6 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | 10a1d1838492b8ce6dea08844353b51571432c56 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | d824e46c8040b0bb9235f9b8a2b35386b303caa0 | |
| ToppCell | Healthy_donor-Treg|Healthy_donor / disease group, cell group and cell class (v2) | 2.77e-05 | 174 | 150 | 6 | 1d76921c8404b5be5fbe9f3157d53578033f2ad2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 176 | 150 | 6 | 03d194c9814e12802cd932afade69e868814cb78 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 176 | 150 | 6 | de746cdf2c777eec88cb03863e128e97ad6e8fb0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 178 | 150 | 6 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 178 | 150 | 6 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-05 | 178 | 150 | 6 | a62137d7f5fac16619f8a02844cdb0be7a794bf2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 181 | 150 | 6 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.45e-05 | 181 | 150 | 6 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 181 | 150 | 6 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.56e-05 | 182 | 150 | 6 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 182 | 150 | 6 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-05 | 183 | 150 | 6 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 3.79e-05 | 184 | 150 | 6 | c294cd421f277992b56ae9c40b8f3948e33148fe | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-05 | 184 | 150 | 6 | 27cb9b5fdb157a1bd72eb0f10662bfac9359cf31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-05 | 184 | 150 | 6 | 7bc10c411c8f5b1bc64da48d6d75751086689b1d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Endo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-05 | 184 | 150 | 6 | 0fdb5d3879b5d3affc139f2c2bb250a71732869d | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 185 | 150 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.90e-05 | 185 | 150 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.02e-05 | 186 | 150 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-05 | 188 | 150 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.66e-05 | 191 | 150 | 6 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 191 | 150 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.80e-05 | 192 | 150 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.80e-05 | 192 | 150 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.80e-05 | 192 | 150 | 6 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.53e-05 | 197 | 150 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-05 | 198 | 150 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.85e-05 | 199 | 150 | 6 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.85e-05 | 199 | 150 | 6 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.02e-05 | 200 | 150 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.02e-05 | 200 | 150 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 9.43e-05 | 135 | 150 | 5 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 137 | 150 | 5 | 306b11b3b9e5fd562d845fb5eaa4ac982864efce | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 137 | 150 | 5 | d37f425b13bc046baa1f8619b98a16b936f88ff6 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 143 | 150 | 5 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 143 | 150 | 5 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 144 | 150 | 5 | 1c118b22c2ff3a526a5207d6c9d772636ee065fd | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 145 | 150 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 146 | 150 | 5 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_atypical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 148 | 150 | 5 | b7b5521162effc1024e7c399f690cd86d0b2f750 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(2)_48hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.45e-04 | 148 | 150 | 5 | a061a745c09254e063411b7d835d5597a0007e29 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 149 | 150 | 5 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-04 | 149 | 150 | 5 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-04 | 149 | 150 | 5 | 2624ad3926efc9f0f169daae263cef16861f132b | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 80 | 150 | 4 | 0d02b242164d27f38f70ed77b106612fc7a3abca | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 80 | 150 | 4 | 313344cf7309bc17ca131b92a91b24489df577e2 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Tmem2_(Tmem2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 80 | 150 | 4 | b95e4456adb7f7d42825351f010376c10bb35380 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte2_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.55e-04 | 150 | 150 | 5 | 6d65df8c0937b498585d1e79919ec73daa354e21 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 151 | 150 | 5 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 151 | 150 | 5 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 151 | 150 | 5 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | COVID-19_Mild-PLT_5|World / Disease Group and Platelet Clusters | 1.64e-04 | 152 | 150 | 5 | 90ba4e8a735ec8921038fa072129535f0e3fd9ae | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 154 | 150 | 5 | b0735365de153d4586ca17896431d7bd9c7d8eac | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.86e-04 | 156 | 150 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 158 | 150 | 5 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 2.03e-04 | 159 | 150 | 5 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 161 | 150 | 5 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 2.15e-04 | 161 | 150 | 5 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 161 | 150 | 5 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-04 | 162 | 150 | 5 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-04 | 162 | 150 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 162 | 150 | 5 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-04 | 162 | 150 | 5 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 162 | 150 | 5 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 162 | 150 | 5 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.41e-04 | 165 | 150 | 5 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.47e-04 | 166 | 150 | 5 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 166 | 150 | 5 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 169 | 150 | 5 | df2c9c706bfc9db2bc5726602a49f5f5a94e9481 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 169 | 150 | 5 | f6a6d2f614d60395ad9b867ff1cf59eba72b04ce | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.76e-04 | 170 | 150 | 5 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 170 | 150 | 5 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 170 | 150 | 5 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.76e-04 | 170 | 150 | 5 | cc66ac6846c58be9493eb270644ee3ce0f86cfea | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-04 | 171 | 150 | 5 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Megakaryocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.84e-04 | 171 | 150 | 5 | 9dda25df493766723335851b3c3d89735b6e8051 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 171 | 150 | 5 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-04 | 171 | 150 | 5 | 846a9acfff0bf0a9baf65dc07b7d7a9217ed6598 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-04 | 172 | 150 | 5 | fe3d0d8cb5f613ac2cfff450599698f1533a354f | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 172 | 150 | 5 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.99e-04 | 173 | 150 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 173 | 150 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| Drug | NSC740136 | 5.75e-07 | 109 | 148 | 8 | CID000003706 | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | MICAL1 HSPB3 SWAP70 ZNF862 ACAD10 SEMA3G ATP8B2 DDX3X UBA7 ATP2A3 | 7.43e-07 | 199 | 148 | 10 | 6818_UP |
| Drug | tritanol | 1.17e-06 | 13 | 148 | 4 | CID000006457 | |
| Drug | anisole | 3.48e-06 | 36 | 148 | 5 | CID000007519 | |
| Drug | bevirimat | 3.48e-06 | 36 | 148 | 5 | CID000457928 | |
| Drug | thymoquinone | 5.94e-06 | 40 | 148 | 5 | CID000010281 | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.14e-06 | 198 | 148 | 9 | 2898_DN | |
| Drug | AC1L1G0K | 1.64e-05 | 49 | 148 | 5 | CID000003473 | |
| Drug | AzMC | 1.95e-05 | 25 | 148 | 4 | CID000064986 | |
| Drug | (+/-)-Abacavir | 2.00e-05 | 51 | 148 | 5 | CID000001971 | |
| Drug | AC1MRQNQ | 2.20e-05 | 9 | 148 | 3 | CID003522271 | |
| Drug | DHPASiU | 2.20e-05 | 9 | 148 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 2.20e-05 | 9 | 148 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 2.20e-05 | 9 | 148 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 2.20e-05 | 9 | 148 | 3 | CID005460873 | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.04e-05 | 186 | 148 | 8 | 6793_UP | |
| Drug | tolcapone | 4.12e-05 | 30 | 148 | 4 | CID004659569 | |
| Drug | paricalcitol | 4.12e-05 | 30 | 148 | 4 | CID005281104 | |
| Drug | dihydroartemisinin | 4.12e-05 | 30 | 148 | 4 | CID000107770 | |
| Drug | AC1L96GB | 4.20e-05 | 2 | 148 | 2 | CID000438977 | |
| Drug | ochrephilone | 4.20e-05 | 2 | 148 | 2 | CID006451074 | |
| Drug | isorotiorin | 4.20e-05 | 2 | 148 | 2 | CID006451070 | |
| Drug | NSC-685994 | 4.20e-05 | 2 | 148 | 2 | CID000389654 | |
| Drug | 5-bromoochrephilone | 4.20e-05 | 2 | 148 | 2 | CID006475613 | |
| Drug | dechloroisochromophilone III | 4.20e-05 | 2 | 148 | 2 | CID006475611 | |
| Drug | phlorobenzophenone | 4.20e-05 | 2 | 148 | 2 | CID000077093 | |
| Drug | diED66Br | 4.20e-05 | 2 | 148 | 2 | CID000124026 | |
| Drug | FYICFVED | 4.20e-05 | 2 | 148 | 2 | CID000462207 | |
| Drug | FYICFVEDE | 4.20e-05 | 2 | 148 | 2 | CID000462209 | |
| Drug | K7H[Nb6O19] | 4.20e-05 | 2 | 148 | 2 | CID006334757 | |
| Drug | O6-ethylguanine | 4.20e-05 | 2 | 148 | 2 | CID000095805 | |
| Drug | afloqualone | 4.20e-05 | 2 | 148 | 2 | ctd:C033541 | |
| Drug | NF036 | 4.20e-05 | 2 | 148 | 2 | CID000456048 | |
| Drug | Ms8209 | 4.20e-05 | 2 | 148 | 2 | CID006436189 | |
| Drug | AC1O6F44 | 4.20e-05 | 2 | 148 | 2 | CID006473854 | |
| Drug | isochromophilone I | 4.20e-05 | 2 | 148 | 2 | CID006473852 | |
| Drug | 4-nitrophenyl)imidazole | 4.27e-05 | 11 | 148 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 4.27e-05 | 11 | 148 | 3 | CID006442661 | |
| Drug | LY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 1216_UP | |
| Drug | ABT-538 | 5.29e-05 | 148 | 148 | 7 | CID000005076 | |
| Drug | Muracein C | 5.35e-05 | 32 | 148 | 4 | CID003086323 | |
| Drug | N-OH-DABZ | 5.67e-05 | 12 | 148 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 5.67e-05 | 12 | 148 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 5.67e-05 | 12 | 148 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 5.67e-05 | 12 | 148 | 3 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 5.67e-05 | 12 | 148 | 3 | CID000276709 | |
| Drug | 5-azido-UDP-glucuronic acid | 7.34e-05 | 13 | 148 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 7.34e-05 | 13 | 148 | 3 | CID000000411 | |
| Drug | muraglitazar | 8.59e-05 | 36 | 148 | 4 | CID000206044 | |
| Drug | glucoraphanin | 8.59e-05 | 36 | 148 | 4 | CID000656556 | |
| Drug | propranolol glucuronide | 9.30e-05 | 14 | 148 | 3 | CID000119515 | |
| Drug | PCB-61 | 9.30e-05 | 14 | 148 | 3 | CID000036401 | |
| Drug | acacetin | 1.07e-04 | 38 | 148 | 4 | CID005280442 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.16e-04 | 15 | 148 | 3 | CID000040469 | |
| Drug | afloqualone | 1.16e-04 | 15 | 148 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 1.16e-04 | 15 | 148 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.16e-04 | 15 | 148 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.16e-04 | 15 | 148 | 3 | CID000543743 | |
| Drug | 411 F | 1.25e-04 | 3 | 148 | 2 | CID005487402 | |
| Drug | Cpf Ester | 1.25e-04 | 3 | 148 | 2 | CID000122104 | |
| Drug | AC1O52PL | 1.25e-04 | 3 | 148 | 2 | CID006451069 | |
| Drug | batzelladine D | 1.25e-04 | 3 | 148 | 2 | CID000460276 | |
| Drug | AC1LA22U | 1.25e-04 | 3 | 148 | 2 | CID000460273 | |
| Drug | AC1LA4RF | 1.25e-04 | 3 | 148 | 2 | CID000461688 | |
| Drug | SFLTKGPS | 1.25e-04 | 3 | 148 | 2 | CID000460311 | |
| Drug | JM2766 | 1.25e-04 | 3 | 148 | 2 | CID006334731 | |
| Drug | MPBH | 1.25e-04 | 3 | 148 | 2 | CID000126744 | |
| Drug | AC1MHUPJ | 1.25e-04 | 3 | 148 | 2 | CID003011739 | |
| Drug | ADS-J1 | 1.25e-04 | 3 | 148 | 2 | CID005481373 | |
| Drug | 12p1 | 1.25e-04 | 3 | 148 | 2 | CID000516475 | |
| Drug | AC1LA1TJ | 1.25e-04 | 3 | 148 | 2 | CID000480003 | |
| Drug | MePEG aldehyde | 1.25e-04 | 3 | 148 | 2 | CID003081726 | |
| Drug | quercetin-3,4'-diglucoside | 1.42e-04 | 16 | 148 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.42e-04 | 16 | 148 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.42e-04 | 16 | 148 | 3 | CID005497144 | |
| Drug | AC1NFJIQ | 1.58e-04 | 42 | 148 | 4 | CID004659568 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.71e-04 | 17 | 148 | 3 | CID000003573 | |
| Drug | acridone | 1.71e-04 | 17 | 148 | 3 | CID000002015 | |
| Drug | 6-hydroxychrysene | 1.71e-04 | 17 | 148 | 3 | CID000037766 | |
| Drug | androsterone glucuronide | 1.74e-04 | 43 | 148 | 4 | CID000114833 | |
| Drug | SureCN12722713 | 2.04e-04 | 18 | 148 | 3 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.04e-04 | 18 | 148 | 3 | CID000152226 | |
| Drug | Br 2 | 2.04e-04 | 18 | 148 | 3 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.04e-04 | 18 | 148 | 3 | CID000036614 | |
| Drug | ApApG | 2.04e-04 | 18 | 148 | 3 | CID003081975 | |
| Drug | C1 11-32 | 2.04e-04 | 18 | 148 | 3 | CID000443077 | |
| Drug | C11131 | 2.04e-04 | 18 | 148 | 3 | CID000443076 | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; HL60; HT_HG-U133A | 2.20e-04 | 186 | 148 | 7 | 2426_DN | |
| Drug | 9-OH-risperidone | 2.42e-04 | 19 | 148 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.42e-04 | 19 | 148 | 3 | CID000091433 | |
| Drug | almokalant | 2.42e-04 | 19 | 148 | 3 | CID003033962 | |
| Drug | AC1NUJ7X | 2.50e-04 | 4 | 148 | 2 | CID005480372 | |
| Drug | 19,20-epoxycytochalasin Q | 2.50e-04 | 4 | 148 | 2 | CID006479878 | |
| Drug | anibamine | 2.50e-04 | 4 | 148 | 2 | CID006479877 | |
| Drug | RD6-Y664 | 2.50e-04 | 4 | 148 | 2 | CID000454219 | |
| Drug | dihydropinosylvin | 2.50e-04 | 4 | 148 | 2 | CID000442700 | |
| Drug | RD6-2198 | 2.50e-04 | 4 | 148 | 2 | CID000470802 | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; HL60; HT_HG-U133A | 2.51e-04 | 190 | 148 | 7 | 2456_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 2675_DN | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 6789_UP | |
| Disease | X-11793--oxidized bilirubin measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 6.66e-06 | 8 | 147 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 9.95e-06 | 9 | 147 | 3 | EFO_0004570, GO_0009410 | |
| Disease | xanthurenate measurement | 1.27e-05 | 29 | 147 | 4 | EFO_0010551 | |
| Disease | bilirubin measurement, response to tenofovir | 1.42e-05 | 10 | 147 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.42e-05 | 10 | 147 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.42e-05 | 10 | 147 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.42e-05 | 10 | 147 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 1.94e-05 | 11 | 147 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.94e-05 | 11 | 147 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.94e-05 | 11 | 147 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.94e-05 | 11 | 147 | 3 | EFO_0010219 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 2.47e-05 | 2 | 147 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Familial primary hypomagnesemia with normocalciuria and normocalcemia | 2.47e-05 | 2 | 147 | 2 | C4510731 | |
| Disease | p-cresol glucuronide measurement | 2.58e-05 | 12 | 147 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 2.58e-05 | 12 | 147 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 3.34e-05 | 13 | 147 | 3 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 7.83e-05 | 17 | 147 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 9.36e-05 | 18 | 147 | 3 | EFO_0801382 | |
| Disease | lipid storage disease (implicated_via_orthology) | 1.47e-04 | 4 | 147 | 2 | DOID:9455 (implicated_via_orthology) | |
| Disease | alpha-parvin measurement | 1.47e-04 | 4 | 147 | 2 | EFO_0802271 | |
| Disease | tissue factor measurement | 1.51e-04 | 21 | 147 | 3 | EFO_0010623 | |
| Disease | prostate carcinoma | TET2 TRIO TNC SIDT1 SSBP3 GGCX CDKAL1 CILP2 SLC7A3 EGF BAIAP2L1 SLC20A1 SLC22A2 AMIGO2 | 1.54e-04 | 891 | 147 | 14 | EFO_0001663 |
| Disease | QRS duration, response to sulfonylurea | 1.99e-04 | 23 | 147 | 3 | EFO_0005055, EFO_0007922 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 2.44e-04 | 5 | 147 | 2 | C3542021 | |
| Disease | response to bevacizumab, Proteinuria | 2.44e-04 | 5 | 147 | 2 | EFO_0005943, HP_0000093 | |
| Disease | Becker Muscular Dystrophy | 2.44e-04 | 5 | 147 | 2 | C0917713 | |
| Disease | trefoil factor 1 measurement | 3.65e-04 | 6 | 147 | 2 | EFO_0021865 | |
| Disease | Muscular Dystrophy, Duchenne | 3.65e-04 | 6 | 147 | 2 | C0013264 | |
| Disease | Intellectual Disability | 4.23e-04 | 447 | 147 | 9 | C3714756 | |
| Disease | response to dolutegravir | 4.46e-04 | 30 | 147 | 3 | EFO_0600017 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.64e-04 | 128 | 147 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C0007134 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 5.15e-04 | 131 | 147 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 5.15e-04 | 131 | 147 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 5.15e-04 | 131 | 147 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 5.15e-04 | 131 | 147 | 5 | C3714758 | |
| Disease | alkaline phosphatase measurement | RALGAPA1 TET2 CNNM2 MAP1A SLC26A4 ACAD10 ECI1 SSBP3 ITIH4 MRPL4 CILP2 BAIAP2L1 SLC22A2 MICAL3 | 5.71e-04 | 1015 | 147 | 14 | EFO_0004533 |
| Disease | Juvenile-Onset Still Disease | 5.91e-04 | 135 | 147 | 5 | C0087031 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 6.77e-04 | 8 | 147 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | thyroxine measurement | 8.01e-04 | 83 | 147 | 4 | EFO_0005130 | |
| Disease | Spastic Paraplegia | 8.67e-04 | 9 | 147 | 2 | C0037772 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.95e-04 | 148 | 147 | 5 | C0279702 | |
| Disease | serum metabolite measurement | RALGAPA1 TRIO ZNF862 UGT1A5 PYROXD2 CKAP5 CDKAL1 UGT1A4 UGT1A3 LINC01565 PARP4 SLC22A2 CSMD1 | 9.23e-04 | 945 | 147 | 13 | EFO_0005653 |
| Disease | eosinophil count | TET2 RAPGEF6 CARMIL2 UNC13D ACAD10 XPO1 UBASH3A ATF6B ITIH4 GGCX LINC01565 CILP2 MDN1 BTN2A3P USP15 ATP2A3 ZNF292 | 1.22e-03 | 1488 | 147 | 17 | EFO_0004842 |
| Disease | pregnenetriol sulfate measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0600039 | |
| Disease | bilirubin measurement | 1.74e-03 | 442 | 147 | 8 | EFO_0004570 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.85e-03 | 13 | 147 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | pregnenetriol disulfate measurement | 1.85e-03 | 13 | 147 | 2 | EFO_0800587 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.12e-03 | 51 | 147 | 3 | cv:CN043650 | |
| Disease | T wave morphology measurement | 2.16e-03 | 14 | 147 | 2 | EFO_0008398 | |
| Disease | Lymphoma, Follicular, Grade 2 | 2.48e-03 | 15 | 147 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 2.48e-03 | 15 | 147 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 2.48e-03 | 15 | 147 | 2 | C1956130 | |
| Disease | P wave duration | 2.48e-03 | 15 | 147 | 2 | EFO_0005094 | |
| Disease | Lymphoma, Large-Cell, Follicular | 2.48e-03 | 15 | 147 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 2.48e-03 | 15 | 147 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 2.48e-03 | 15 | 147 | 2 | C0079758 | |
| Disease | lymphocyte count | TET2 CARMIL2 SLC26A4 ACAD10 UBASH3A LYST FOCAD CILP2 TENM4 EGF BAIAP2L1 BTN2A3P MICAL3 PPIP5K2 ATL2 HSF2 | 2.66e-03 | 1464 | 147 | 16 | EFO_0004587 |
| Disease | Malignant neoplasm of breast | MICAL1 ATG10 DYNC2H1 UBR4 FRMPD1 ELP1 SLC2A1 DDX3X EGF MTR UTP20 TREML1 ATP2A3 | 2.85e-03 | 1074 | 147 | 13 | C0006142 |
| Disease | urate measurement, spine bone mineral density | 3.06e-03 | 58 | 147 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | IGF-1 measurement | 3.19e-03 | 488 | 147 | 8 | EFO_0004627 | |
| Disease | X-21441 measurement | 3.19e-03 | 17 | 147 | 2 | EFO_0800814 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.19e-03 | 17 | 147 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 3.21e-03 | 59 | 147 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.53e-03 | 61 | 147 | 3 | DOID:3587 (is_marker_for) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.58e-03 | 18 | 147 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Prostatic Neoplasms | 3.84e-03 | 616 | 147 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.84e-03 | 616 | 147 | 9 | C0376358 | |
| Disease | pulse pressure measurement | TET2 CNNM2 SWAP70 DYNC2H1 CKAP5 UNC13D ACAD10 CDKAL1 MRPL4 CILP2 PSMG2 TENM4 SLC22A2 SCN10A KLB | 4.11e-03 | 1392 | 147 | 15 | EFO_0005763 |
| Disease | calcium measurement | 4.35e-03 | 628 | 147 | 9 | EFO_0004838 | |
| Disease | neutrophil count, eosinophil count | 4.36e-03 | 213 | 147 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 4.42e-03 | 20 | 147 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | Lymphoma, Follicular | 4.42e-03 | 20 | 147 | 2 | C0024301 | |
| Disease | Parkinson's disease (is_marker_for) | 4.60e-03 | 67 | 147 | 3 | DOID:14330 (is_marker_for) | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.60e-03 | 67 | 147 | 3 | C3463824 | |
| Disease | tuberculosis | 4.63e-03 | 216 | 147 | 5 | MONDO_0018076 | |
| Disease | red blood cell density measurement | RALGAPA1 VIL1 TET2 ACAD10 ATP8B2 CDKAL1 FOCAD LINC01565 AFDN HSF2 MUC4 | 4.70e-03 | 880 | 147 | 11 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLLLLSVQPWAESGK | 16 | P35503 | |
| ALTSLKWILSLEEPL | 401 | Q96KV6 | |
| LQIFREWPSDKGILV | 326 | P55196 | |
| WLSFLKSLVPVEEPI | 856 | P53355 | |
| DLLPTFTTWPLVLEK | 91 | P41214 | |
| FTTWPLVLEKLVGGA | 96 | P41214 | |
| PWDDKLIFKLLSGLS | 741 | O43683 | |
| ILKVWDGPVDSDILL | 1331 | Q96PZ7 | |
| KELAEQGSLWTVLEP | 126 | Q6ZRV3 | |
| SAWLLKDGKVIPISL | 341 | Q9NZJ5 | |
| ELLLKTWLPGEGAVQ | 26 | Q6F5E8 | |
| PASALELKVWLELEV | 76 | P0DPF5 | |
| WKLLGIVGSLAPETL | 46 | O15544 | |
| IFLVTLPLWVDKEAS | 81 | P49685 | |
| GTEAQKARWLIPLLE | 771 | Q6JQN1 | |
| LTLKYPIEHGIITNW | 66 | P63267 | |
| ILPTAEETWLGLKAI | 396 | P48052 | |
| GLLDSEWIPVSFAKL | 81 | Q86SJ2 | |
| EWIPVSFAKLNTLIL | 86 | Q86SJ2 | |
| SFLDGRPLTLKDIWE | 116 | Q9H0Y0 | |
| VFDLAWVPGELKLVT | 101 | Q9NZJ0 | |
| LKEDQWLQTILSLPS | 1566 | Q96PN6 | |
| LPSEEGKSLWELVLE | 41 | Q93084 | |
| LFWDPSLLEAVKIGD | 466 | P98198 | |
| LLSDPDKVTIGLLFW | 836 | Q14624 | |
| SVGFLLEKPDEAVVW | 91 | Q9Y5Y2 | |
| TFEEPGTVHIWKLLL | 226 | Q8N8L6 | |
| LLDLLVEAKQEVPSW | 556 | O00571 | |
| DLELFENGTLLWTPK | 4991 | Q99102 | |
| LWTPKSLEPFTLEIL | 5001 | Q99102 | |
| LLVALVGDSLLEPFW | 391 | Q7RTP6 | |
| LEKALVLANPEVSLW | 231 | Q9NU22 | |
| SDWVKNLISPELGVV | 121 | P78559 | |
| GNKDLWPLLLSIIFI | 181 | P11166 | |
| PFQLVALLGTVWLKE | 256 | P25090 | |
| GFFQKVLTPLLSWLL | 41 | P0DMR3 | |
| LFQDSWTPELKLKLI | 166 | Q7Z3E5 | |
| LPEDIIIQTFEGWLL | 81 | Q12988 | |
| PIVNLKDELLFPSWE | 1641 | P39060 | |
| IEWFTSKEPINLGLL | 171 | Q9UJA9 | |
| WALKVAENELGITPV | 571 | Q8TDZ2 | |
| QDVNPLKLGLLTWIE | 496 | O95163 | |
| LKLGLLTWIEEDVFL | 501 | O95163 | |
| TEDGFWKLTPELGLI | 1581 | Q9UKK3 | |
| WKLTPELGLILNLNT | 1586 | Q9UKK3 | |
| ILGSEELWPVLLGFT | 201 | Q8TDB8 | |
| IFWLLVKSPELAAQP | 256 | Q8NBN7 | |
| LIWKSEGLPSDDLSI | 3251 | Q8NCM8 | |
| LNETQLGIIAPFWLK | 176 | P42126 | |
| LGIIAPFWLKDTLEN | 181 | P42126 | |
| QELLGWLAEKLPTLR | 996 | Q14008 | |
| LALKILDNGEWTPTL | 351 | P14635 | |
| PELKQITWLSVTGLL | 151 | O60725 | |
| TLVAGTIWNLKDIIP | 251 | Q7Z4Q2 | |
| LIKDVDWFLLGSPIE | 126 | Q86XP6 | |
| VITLLIPEEKDGWLY | 366 | Q9UHR4 | |
| VETQVGYSWLPLLKD | 751 | Q9BZ29 | |
| LEKVLPWLGAIDDSV | 1146 | O14981 | |
| LIWPSGITIDFLTDK | 641 | P01133 | |
| SSYGKLLLIPAVIWE | 186 | Q9H2C2 | |
| DIGTNLPTLLWKLVE | 266 | Q5VV42 | |
| IEKDWGIENFISPTL | 331 | Q5SYB0 | |
| IEKEWGLETFLPSAV | 356 | Q14CM0 | |
| EVLLDPYIASWKGLV | 26 | Q5TA50 | |
| KLLGEFSWLTEEILL | 476 | Q6NUI2 | |
| QIAETLWEQVLKPLG | 536 | Q8NHH9 | |
| GQVLLESNIKVLPTW | 376 | P01730 | |
| LFQKWSVIPILGLIE | 2421 | Q99698 | |
| LGDLVKLWITINEPN | 681 | Q86Z14 | |
| NGEFIILLVSSLKIW | 1756 | Q05BV3 | |
| LNSKLPVDILGRVWE | 156 | P42566 | |
| ILELPWKEETFLVLQ | 441 | Q9HB96 | |
| LDLKNIVLTTPWIGD | 256 | Q6UWX4 | |
| IITWLLLLFGQGVKT | 91 | Q9BZV2 | |
| LGFDKLPLWGTILIS | 221 | Q8WUM9 | |
| SVFIPGDLQWLKIII | 421 | O15244 | |
| LEWLTPLKFIQISQE | 1031 | Q9NZJ4 | |
| TIFRKEGLEAWPQLL | 106 | Q8TEX9 | |
| TESEKLTLWGLFFPL | 451 | Q8WY07 | |
| PLWIKHISDEQILGF | 1471 | Q5VW36 | |
| SILDWSPILEGFLKK | 2401 | Q8TE73 | |
| LLVALVGDSLLEPFW | 391 | O94851 | |
| ILLGLTQDPFWKKIV | 11 | Q8NGL9 | |
| NVPAFLSKLWTLVEE | 6 | Q03933 | |
| TEVKLEPDGLLVWVL | 516 | Q6J4K2 | |
| SWELIIDPNLKPSEL | 26 | Q5QGT7 | |
| EPLGFIKVLEWIASI | 31 | Q16563 | |
| LEEPLGFIKVLQWLF | 31 | Q5VXT5 | |
| TLDIGWQLLRIFPKE | 476 | P21281 | |
| EELGRPATLLWLIQK | 2611 | O75691 | |
| LESPLDVGIKLLEWF | 451 | Q8TEU7 | |
| LSEIRWEKNITLGEP | 41 | Q9BWW4 | |
| LTLPTVAFLEDKLLW | 261 | Q9BYD3 | |
| LIVLGLPWKTTEQDL | 106 | Q13148 | |
| DPWVLQTLGLKDLDT | 186 | A6NCL1 | |
| NISVAEVEKWLGPIL | 1246 | Q99707 | |
| PLKAWLDTITVFVGE | 226 | Q9H156 | |
| LTPLRNFLEGDWKTI | 141 | Q9NR46 | |
| SWKAFLGELTLQLLP | 111 | Q149N8 | |
| DIWKIPDISSFLLGH | 281 | Q9H5K3 | |
| QPWGLGSLEELETVK | 2236 | Q9P2P6 | |
| LLQPLEGKNISTVLW | 556 | Q7Z745 | |
| TWILHILESKFLETP | 1856 | O60287 | |
| GWLLLQESVLGKPEL | 1366 | Q7RTU9 | |
| FPLNKSWIIALGITV | 256 | Q7Z7B1 | |
| DEIFLTPNLSLPLWE | 941 | Q8WZ75 | |
| ILYSDLGLPKELTLW | 81 | Q14201 | |
| WELLPIFPDLQVKSE | 76 | Q99941 | |
| VEALKLWSLNPETGL | 676 | Q8IUL8 | |
| GEEKKFLLPFWLQVI | 246 | Q9H8M5 | |
| PGSQDLWEAKILLLS | 136 | Q3KNT9 | |
| DLYLPKSWTIQVGLV | 261 | P57727 | |
| FLLDLGKLIIQWNGP | 166 | P09327 | |
| IPPTQFKLVLDSIIW | 866 | O14980 | |
| VFLGIAVSKPDLITW | 41 | Q03936 | |
| LFLPVEAGKEIQETW | 306 | Q7Z2Z1 | |
| WLFSPFKLLLSEELT | 236 | P38435 | |
| LAGPLFQTLIVAWIK | 616 | Q6GYQ0 | |
| AFGVLKTLVPILEWL | 61 | O43511 | |
| LPGSQDWTALRELLK | 741 | P41226 | |
| ITFLKLTPQEWLPEE | 346 | Q8N2H3 | |
| LVLKLPWTQVGFSLL | 16 | Q6P1M0 | |
| WVKLKTILFGLVTDP | 651 | Q9Y5Y9 | |
| FGPKLLQLLAEWTET | 106 | Q8N431 | |
| WGLPLKVLESIEIFK | 916 | Q6ZQQ2 | |
| KEVLSWQVPLLFQGL | 101 | Q9NXL6 | |
| LGFTPEEWGLLDLKQ | 21 | Q96GC6 | |
| LEQFLGALPVKLRTW | 206 | Q96GC6 | |
| ITWFKPLAEIDGIEL | 821 | P24821 | |
| ELLLVLKTQWPFDPE | 431 | O60281 | |
| EEGFLKLWQGVTPAI | 81 | O95847 | |
| LLLLLSVQPWAESGK | 16 | P35504 | |
| ELDYILLPTEGWNKL | 86 | Q9Y4E8 | |
| LDVAFLWKAVLTLGL | 6 | Q9NQQ7 | |
| PDLILWEKRTTVLQG | 1146 | Q6N022 | |
| PWFSGKKVIALTLDL | 826 | P08922 | |
| LVNWLFVLTEPELTG | 41 | Q6ZVL8 | |
| ETLLQAKGEPWTFLV | 121 | P29350 | |
| WPVQGIEDSFHKLIL | 86 | Q15928 | |
| EEWLGLKTIAQHLPF | 991 | O60290 | |
| EWLQILKPLSDDPTV | 226 | Q969U7 | |
| DVFLLWPKAGKSLEV | 311 | Q9NS98 | |
| ELGWLLLQESVLGKP | 1361 | A6NGW2 | |
| LLQESVLGKPELWSQ | 1366 | A6NGW2 | |
| NPLLITEEDAFKIWV | 106 | Q9UH65 | |
| VLLWVKAEPFIVGAL | 6 | Q9NVR7 | |
| EEPSLLLVLKWGGEL | 501 | O43314 | |
| WATIEGLVELLQPFK | 391 | O96006 | |
| LKELLTQPGDWTLFV | 521 | Q15063 | |
| QDEKSIPLIWGAVLL | 156 | Q86YW5 | |
| FIIKAVWLPGSQTEL | 2001 | Q5T4S7 | |
| LVWEGIPLSLADKLY | 1231 | Q6N021 | |
| VIGKLPAQLAWEALE | 711 | Q70J99 | |
| GFDVLIDSTLKPWLL | 351 | Q6EMB2 | |
| IDSTLKPWLLEVNLS | 356 | Q6EMB2 | |
| LILQESFQVWDPKTL | 1486 | O75962 | |
| TGPLLEKLQEFWRES | 81 | P57075 | |
| ALTKLEQGEPLWTLE | 56 | Q9BS31 | |
| LLLLLSVQPWAESGK | 16 | P22310 | |
| SSDLQVGVIKPWLLL | 61 | Q8WTR2 | |
| LALFEVLSLKGWVEV | 1106 | Q8IZF0 |